GOLDEN THROAT HOLDINGS GROUP COMPANY LIMITED

Golden Throat Holdings Group Company Limited

6896

KYG3961J1022

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:09:02 2024-07-04 EDT			5-day change	1st Jan Change
3.13 ^HKD	+0.64%		+1.95%	-6.57%

06-05	Golden Throat Holdings Group Company Limited Approves Appointment of Qin Jiesheng as Independent Non-Executive Director and Member of the Audit Committee	CI
06-05	Golden Throat Holdings Group Company Limited Approves Final Dividend for the Year Ended 31 December 2023	CI

Golden Throat Holdings Group Company Limited Approves Final Dividend for the Year Ended 31 December 2023

June 05, 2024 at 07:40 am

Golden Throat Holdings Group Company Limited at its AGM held on June 5, 2024 approved final dividend of HKD 0.6 per share for the year ended 31 December 2023.

Latest news about Golden Throat Holdings Group Company Limited

Golden Throat Holdings Group Company Limited Approves Appointment of Qin Jiesheng as Independent Non-Executive Director and Member of the Audit Committee	06-05	CI
Golden Throat Holdings Group Company Limited Approves Final Dividend for the Year Ended 31 December 2023	06-05	CI
Golden Throat’s Profit Declines 11% in 2023	05-01	MT
Golden Throat Holdings Group Company Limited Updates to Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 26 June 2024	03-27	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Golden Throat’s Profit to See 110% Boost in H1	23-08-15	MT
Golden Throat Holdings Group Company Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023	23-08-14	CI
Golden Throat Holdings Group Company Limited Declares Final Dividend for the Year Ended 31 December 2022	23-06-14	CI
Golden Throat Holdings Group Company Limited Proposes Final Dividend for the Year Ended 31 December 2022	23-05-17	CI
Golden Throat Holdings Group Company Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 30 June 2023	23-03-29	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Golden Throat Forecasts 50% Rise in 2022 Profit; Shares Climb 7%	23-03-10	MT
Golden Throat Holdings Group Company Limited Provides Earnings Guidance for the Year Ended 31 December 2022	23-03-09	CI
Golden Throat Holdings Group's H1 Net Profit Falls 30.4%	22-08-25	MT
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Golden Throat Warns of 30% Profit Drop in H1	22-08-05	MT
Golden Throat Holdings Group Company Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2022	22-08-05	CI
Golden Throat Holdings Group Company Limited Proposes Final Dividend for the Year Ended 31 December 2021, Payable on 13 June 2022	22-03-30	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Golden Throat Holdings Group Company Limited Announces Resignation of Lu Xinghong as Executive Director	22-03-25	CI
Golden Throat Holdings Group Company Limited Provides Earnings Guidance for the Fiscal Year Ended December 31, 2021	22-03-16	CI
Golden Throat Holdings Group Company Limited Announces Management Changes	22-03-09	CI
Hong Kong Stocks Rebound from 14-Month Low; Golden Throat Tanks 38%	21-12-01	MT
Golden Throat Shareholders Reject $68 Million Go-Private Offer; Shares Tank 34%	21-12-01	MT

Chart Golden Throat Holdings Group Company Limited

Duration

Period

Chart Golden Throat Holdings Group Company Limited

More charts

Golden Throat Holdings Group Co Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical, healthcare food and other products. The Company has three products categories that include Golden Throat Lozenges (Over the Counter), which is designed to relieve symptoms of sore and dry throat and hoarse voice caused by acute pharyngitis, Golden Throat Series Products including Dule Lozenges and others, and other products including Yinxingye Tablet, Golden Throat Intestinal Series and others. The Company mainly conducts its business in the domestic and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
GOLDEN THROAT HOLDINGS GROUP COMPANY LIMITED	-6.57%	294M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+23.70%	44.09B
OTSUKA HOLDINGS CO., LTD.	+30.04%	23.18B
SANDOZ GROUP AG	+24.02%	15.66B
CIPLA LIMITED	+18.81%	14.35B
ZYDUS LIFESCIENCES LIMITED	+64.98%	13.2B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.78%	6.45B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.11%	5.63B